This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chadee, K. Articles by Meerovitch, E. Search for Related Content PubMed PubMed Citation Articles by Chadee, K. Articles by Meerovitch, E.

American Journal of Pathology, Vol 117, 71-80, Copyright © 1984 by American Society for Investigative Pathology

REGULAR ARTICLES

The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus)

K Chadee and E Meerovitch

Sequential development and pathology of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus) were studied from 1 to 60 days after inoculation. Early lesions were characterized by an acute inflammatory response, which became granulomatous at 5 days. Early granulomas were discrete, with well-defined fibrohistiocytic walls. Trophozoite dissemination as a result of fibrolysis of granuloma wall was confined to the liver parenchyma. The granulomatous cellular infiltrate (less than 20 days) was characterized by granulocytes and histiocytes; older granulomas (greater than 30 days) were composed of lymphocytic infiltrate, plasma cells, and a few granulocytes, and were characterized by the absence of epithelioid histiocytes. The degree of pathologic change adjacent to liver granulomas followed the sequential development of the amebic liver abscess. Severe changes observed were portal canal lymphocytic infiltration, the presence of foreign body giant cells, periportal fibrosis, proliferation of bile duct epithelium, and hepatocyte anisonucleosis and ballooning degeneration. The pathogenesis of the infection and the usefulness of the gerbil model for the study of human amebiasis are discussed.

This article has been cited by other articles:

				C. P. A. Ivory, M. Prystajecky, C. Jobin, and K. Chadee Toll-Like Receptor 9-Dependent Macrophage Activation by Entamoeba histolytica DNA Infect. Immun., January 1, 2008; 76(1): 289 - 297. [Abstract] [Full Text] [PDF]

				C. P. A. Ivory and K. Chadee Intranasal Immunization with Gal-Inhibitable Lectin plus an Adjuvant of CpG Oligodeoxynucleotides Protects against Entamoeba histolytica Challenge Infect. Immun., October 1, 2007; 75(10): 4917 - 4922. [Abstract] [Full Text] [PDF]

				H. Lotter, T. Jacobs, I. Gaworski, and E. Tannich Sexual Dimorphism in the Control of Amebic Liver Abscess in a Mouse Model of Disease Infect. Immun., January 1, 2006; 74(1): 118 - 124. [Abstract] [Full Text] [PDF]

				C. P. A. Ivory, K. Keller, and K. Chadee CpG-Oligodeoxynucleotide Is a Potent Adjuvant with an Entamoeba histolytica Gal-Inhibitable Lectin Vaccine against Amoebic Liver Abscess in Gerbils Infect. Immun., January 1, 2006; 74(1): 528 - 536. [Abstract] [Full Text] [PDF]

				D. Moncada, K. Keller, and K. Chadee Entamoeba histolytica Cysteine Proteinases Disrupt the Polymeric Structure of Colonic Mucin and Alter Its Protective Function Infect. Immun., February 1, 2003; 71(2): 838 - 844. [Abstract] [Full Text] [PDF]

				X. Que and S. L. Reed Cysteine Proteinases and the Pathogenesis of Amebiasis Clin. Microbiol. Rev., April 1, 2000; 13(2): 196 - 206. [Abstract] [Full Text] [PDF]

				H. Lotter, T. Zhang, K. B. Seydel, S. L. Stanley Jr., and E. Tannich Identification of an Epitope on the Entamoeba histolytica 170-kD Lectin Conferring Antibody-mediated Protection against Invasive Amebiasis J. Exp. Med., May 19, 1997; 185(10): 1793 - 1801. [Abstract] [Full Text] [PDF]